178 related articles for article (PubMed ID: 11938761)
1. [Significance of human telomerase RNA expression in situ in malignant melanoma].
Wei Q; Fen S
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):107-9. PubMed ID: 11938761
[TBL] [Abstract][Full Text] [Related]
2. In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
Vagner J; Steiniche T; Stougaard M
Histopathology; 2015 Apr; 66(5):747-51. PubMed ID: 25601620
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
4. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.
Minami S; Lum CA; Kitagawa KM; Namiki TS
Int J Dermatol; 2011 Jan; 50(1):24-9. PubMed ID: 21182498
[TBL] [Abstract][Full Text] [Related]
6. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
7. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
[TBL] [Abstract][Full Text] [Related]
8. Telomerase expression in sebaceous carcinoma of the eyelid.
Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX
Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789
[TBL] [Abstract][Full Text] [Related]
9. [Expression of telomerase and p53 in ameloblastoma].
Zhong M; Zhang LH; Wang J; Zhang B; Hou L
Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519
[TBL] [Abstract][Full Text] [Related]
10. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.
Ramirez RD; D'Atri S; Pagani E; Faraggiana T; Lacal PM; Taylor RS; Shay JW
Neoplasia; 1999 Apr; 1(1):42-9. PubMed ID: 10935469
[TBL] [Abstract][Full Text] [Related]
11. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; Aurues T; Ikeda T
Cancer; 1999 Nov; 86(10):2109-16. PubMed ID: 10570439
[TBL] [Abstract][Full Text] [Related]
12. In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion.
Ozaki S; Harada K; Sanzen T; Watanabe K; Tsui W; Nakanuma Y
Hepatology; 1999 Oct; 30(4):914-9. PubMed ID: 10498642
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Ikeda S; Shibata T; Funakoshi N
Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
[TBL] [Abstract][Full Text] [Related]
14. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
Cho-Vega JH; Vega F; Schwartz MR; Prieto VG
J Cutan Pathol; 2007 Jul; 34(7):535-42. PubMed ID: 17576332
[TBL] [Abstract][Full Text] [Related]
15. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
[TBL] [Abstract][Full Text] [Related]
16. [Telomerase expression in tarsal gland carcinoma].
Li N; Li B; Sun X; Li L; Chen C
Zhonghua Yan Ke Za Zhi; 2002 Nov; 38(11):684-7. PubMed ID: 12487901
[TBL] [Abstract][Full Text] [Related]
17. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in prognostic histopathologic features of melanoma.
Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
[TBL] [Abstract][Full Text] [Related]
20. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
